Nomura Instinet analyst Romit Shah upgraded NXP Semiconductors to Buy with an unchanged price target of $95. The analyst says his call is based largely on valuation with the stock correcting almost 40% from a 52-week high. Investors have largely ignored NXP, "seeing this as a business that is suffering from a two-year engagement with Qualcomm and quite possibly underappreciating an attractive end-market mix," Shah tells investors in a research note.

Susquehanna analyst Christopher Rolland raised the firm's price target on Impinj (PI) to $150 from $140 and keeps a Positive rating on the shares. The firm said they posted a solid print with additional upside driven by the licensing win from NXP Semiconductors (NXPI). Customer engagements and new RFID markets continue to broaden the opportunity.

BofA raised the firm's price target on Texas Instruments (TXN) to $190 from $175 and keeps a Neutral rating on the shares. TI's small Q1 beat and inline but sequentially rising Q2 sales guidance, "while modest, potentially marks a recovery inflection in industrial chip demand," with positive read-across for U.S. peers such as Analog Devices (ADI), Microchip (MCHP), NXP Semiconductors (NXPI) and On Semiconductor (ON), the analyst tells investors. However, despite an expected recovery, TI's sustained high capex intensity could keep reported calendar year 2024-26 pro-forma EPS below $6 per share, the analyst added.